Viemed Healthcare (VMD) Shares Outstanding (Diluted Average) (2018 - 2026)
Viemed Healthcare (VMD) reported Shares Outstanding (Diluted Average) of $40.5 million for Q1 2026, down 2.73% on a YoY basis from $41.6 million in Q1 2025, and down 0.81% quarter-over-quarter from $40.8 million in Q4 2025.
Viemed Healthcare (VMD) Shares Outstanding (Diluted Average) (2018 - 2026) Analysis & Trends
Viemed Healthcare has reported Shares Outstanding (Diluted Average) for 9 years, with the latest figure at $40.5 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 2.73% year-over-year to $40.5 million; the trailing twelve-month figure through Mar 2026 stood at $40.5 million (down 2.73% YoY), and the FY2025 full-year result was $40.8 million, changed 0.05% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $40.5 million, down from $40.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $41.6 million in Q1 2025, with the low at $39.8 million in Q2 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $40.5 million across 5 years, with a median of $40.5 million in 2026.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) declined 3.11% — and 2025, when it advanced 2.58%.
- Viemed Healthcare's Shares Outstanding (Diluted Average) stood at $39.8 million in 2022, then grew by 1.44% to $40.4 million in 2023, then increased by 1.06% to $40.8 million in 2024, then advanced by 0.05% to $40.8 million in 2025, then retreated by 0.81% to $40.5 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $40.5 million (Q1 2026), $40.8 million (Q4 2025), and $41.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Viemed Healthcare | 410.03 Mn | 402.20 Mn | 42.83 Mn | 40.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.49 Mn |
| Dec 31, 2025 | 40.82 Mn |
| Sep 30, 2025 | 41.09 Mn |
| Jun 30, 2025 | 41.08 Mn |
| Mar 31, 2025 | 41.63 Mn |
| Dec 31, 2024 | 40.81 Mn |
| Sep 30, 2024 | 40.78 Mn |
| Jun 30, 2024 | 40.55 Mn |
| Mar 31, 2024 | 40.58 Mn |
| Dec 31, 2023 | 40.38 Mn |
| Sep 30, 2023 | 40.39 Mn |
| Jun 30, 2023 | 40.38 Mn |
| Mar 31, 2023 | 40.02 Mn |
| Dec 31, 2022 | 39.81 Mn |
| Sep 30, 2022 | 39.85 Mn |
| Jun 30, 2022 | 39.75 Mn |
| Mar 31, 2022 | 40.36 Mn |
| Dec 31, 2021 | 40.68 Mn |
| Sep 30, 2021 | 40.72 Mn |
| Jun 30, 2021 | 41.03 Mn |